Production of xenon-133 gas using low-enriched uranium has begun at the High Flux Reactor at Petten in the Netherlands after Curium and the Nuclear Research and Consultancy Group partnered to develop and implement a process to produce the radioisotope. Curium converts the pure bulk of Petten-sourced Xe-133, which can be used to evaluate cerebral blood flow and pulmonary function, as well as for lung imaging, at its sister company in the US.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.